July 10, 2007 - Biospace Med recently announced the introduction of the revolutionary EOS ultra-low dose 2-D/3-D orthopedic X-ray imager that allows images to be obtained with a low dose of radiation, part of a system that is capable of very long length digital imaging, permitting full-body, uninterrupted digital imaging with a single scan.
On the heels of obtaining its CE mark for marketing EOS in Europe and receiving approval from the Health Canada Medical Device Bureau, Biospace Med has filed a 510k application with the FDA to seek clearance to market EOS in the United States.
In addition, the first two commercial installations have been completed and are now operational in Bordeaux, France and Pecs, Hungary. Four other Canadian and European hospitals have been involved during the R&D phase of development and performed over 3,000 images of both adult and pediatric cases.
EOS differs in several respects from a traditional X-ray or CT. One of the most important features is the ability to reportedly capture an accurate, undistorted, full or partial body image with a large reduction in radiation dose. In addition, multi-planar images are obtained simultaneously in an upright, weight-bearing position, which is unavailable with CT.
For more information: www.biospace.eu
July 18, 2024 
